American International Group’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,036
| Closed | -$178K | – | 3163 |
|
|
2021
Q3 | $178K | Sell |
1,036
-79
| -7% | -$10.3K | ﹤0.01% | 2494 |
|
|
2021
Q2 | $140 | Sell |
1,115
-5
| -0.4% | -$631 | ﹤0.01% | 2733 |
|
|
2021
Q1 | $152 | Sell |
1,120
-133
| -11% | -$17.2K | ﹤0.01% | 2510 |
|
|
2020
Q4 | $160 | Sell |
1,253
-51
| -4% | -$5.98K | ﹤0.01% | 2398 |
|
|
2020
Q3 | $147K | Buy |
1,304
+87
| +7% | +$8.66K | ﹤0.01% | 2317 |
|
|
2020
Q2 | $116K | Sell |
1,217
-25,443
| -95% | -$2.45M | ﹤0.01% | 2438 |
|
|
2020
Q1 | $2.4M | Sell |
26,660
-1,541
| -5% | -$120K | 0.01% | 825 |
|
|
2019
Q4 | $1.5M | Sell |
28,201
-238
| -0.8% | -$10.9K | 0.01% | 1129 |
|
|
2019
Q3 | $1.12M | Sell |
28,439
-198
| -0.7% | -$8.59K | ﹤0.01% | 1239 |
|
|
2019
Q2 | $1.18M | Buy |
28,637
+854
| +3% | +$35.4K | ﹤0.01% | 1237 |
|
|
2019
Q1 | $1.29M | Buy |
27,783
+2,306
| +9% | +$101K | ﹤0.01% | 1183 |
|
|
2018
Q4 | $1.11M | Sell |
25,477
-195
| -0.8% | -$9.74K | ﹤0.01% | 1214 |
|
|
2018
Q3 | $1.47M | Buy |
25,672
+462
| +2% | +$22.7K | ﹤0.01% | 1207 |
|
|
2018
Q2 | $1.22M | Buy |
25,210
+1,213
| +5% | +$44.2K | ﹤0.01% | 1261 |
|
|
2018
Q1 | $938K | Sell |
23,997
-1,291
| -5% | -$54.9K | ﹤0.01% | 1313 |
|
|
2017
Q4 | $1.07M | Buy |
25,288
+3,801
| +18% | +$143K | ﹤0.01% | 1330 |
|
|
2017
Q3 | $802K | Buy |
21,487
+1,607
| +8% | +$55.8K | ﹤0.01% | 1480 |
|
|
2017
Q2 | $604K | Buy |
19,880
+3,002
| +18% | +$87K | ﹤0.01% | 1576 |
|
|
2017
Q1 | $447K | Buy |
16,878
+1,119
| +7% | +$29.5K | ﹤0.01% | 1671 |
|
|
2016
Q4 | $402K | Sell |
15,759
-42
| -0.3% | -$1.33K | ﹤0.01% | 1771 |
|
|
2016
Q3 | $572K | Buy |
15,801
+24
| +0.2% | +$795 | ﹤0.01% | 1532 |
|
|
2016
Q2 | $536K | Buy |
15,777
+3,062
| +24% | +$99.5K | ﹤0.01% | 1547 |
|
|
2016
Q1 | $336K | Hold |
12,715
| – | – | ﹤0.01% | 2313 |
|
|
2015
Q4 | $620K | Sell |
12,715
-22
| -0.2% | -$792 | ﹤0.01% | 1860 |
|
|
2015
Q3 | $317K | Buy |
12,737
+15
| +0.1% | +$451 | ﹤0.01% | 2398 |
|
|
2015
Q2 | $403K | Buy |
12,722
+2,378
| +23% | +$76.7K | ﹤0.01% | 2369 |
|
|
2015
Q1 | $394K | Hold |
10,344
| – | – | ﹤0.01% | 2366 |
|
|
2014
Q4 | $403K | Sell |
10,344
-409
| -4% | -$14.3K | ﹤0.01% | 2327 |
|
|
2014
Q3 | $325K | Sell |
10,753
-7
| -0.1% | -$197 | ﹤0.01% | 2511 |
|
|
2014
Q2 | $366K | Buy |
10,760
+6,385
| +146% | +$214K | ﹤0.01% | 2450 |
|
|
2014
Q1 | $151K | Buy |
4,375
+116
| +3% | +$5.24K | ﹤0.01% | 3087 |
|
|
2013
Q4 | $169K | Buy |
+4,259
| New | +$103K | ﹤0.01% | 2906 |
|
American International Group's XLRN Position: Q4 2021 in Review
American International Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,036 shares — an estimated $178K sold.
American International Group first reported a position in XLRN in Q4 2013 and held it in 32 quarters. The position peaked at $2.4M in Q1 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- American International Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- American International Group sold 1,036 Acceleron Pharma shares in Q4 2021, an estimated $178K.
- American International Group first reported a position in Acceleron Pharma in Q4 2013 and held it in 32 quarters.
- American International Group's Acceleron Pharma position peaked at $2.4M in Q1 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on American International Group's 13F filing for Q4 2021, filed 11 Feb 2022.